Polypeptide capable of reinforcing killing activity of NK (natural killer) cells and application of polypeptide
A technology of NK cells and killing activity, applied in the field of life sciences, can solve the problems of inability to mass-produce, clinically uncertain hazards cannot be assessed, and increase costs, etc., to achieve the effect of enhancing killing activity, promoting apoptosis, and increasing expression
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0036] Peptide Design and Synthesis
[0037] The polypeptide of the present invention is derived from gMYL6, combined with the conservative type of gMYL6, truncated and designed to obtain a small molecular polypeptide comprising 15 amino acids in total, and the sequence is shown in SEQ ID NO.1. The polypeptide of the present invention is synthesized by solid-phase synthesis. For the specific synthesis method, refer to the reference Recent Reports of Solid-Phase Cyclohexapeptide Synthesis and Applications. Molecules. 2018 Jun; 23(6): 1475, and the final product is identified by ESI-MS method. The purified peptide mass spectrum is shown in figure 1 . Mass spectrometry analysis showed that the molecular weight of the purified polypeptide was 1789Da, which was consistent with the calculated value.
Embodiment 2
[0039] Culture and phenotype identification of NK cells derived from human umbilical cord blood
[0040] 1) NK cell activation
[0041] Activating and culturing umbilical cord blood NK cells: using lymphocyte medium to adjust the density of umbilical cord blood mononuclear cells to 1-5×10 6 / mL, then add 1mL activated culture factor and 1000IU / mL recombinant human interleukin-2, at 37℃, 5%CO 2 Cultured in a saturated humidity environment for 3 days, and the cell fluid was collected.
[0042] 2) NK cell proliferation
[0043] Cells were obtained from the activated cell liquid, and the cell density was adjusted to 1-5×10 with X-VIVO 15 cell culture medium (LONZA, USA). 6 / mL, then add 1000IU / mL recombinant human interleukin-2, at 37°C, 5% CO 2 Cultured in a saturated humidity environment, supplemented with fresh medium every 3 days and adjusted the cell density to 1-5×10 6 / mL, cultivated for 25 days, and harvested cord blood NK cells.
[0044] 3) Phenotype identification ...
Embodiment 3
[0049] CCK-8 Assay to Detect the Killing Activity of NK Cells on Tumor Cells
[0050] Take the NK cells cultured for 20 days, culture them with the culture medium containing 0 μg / mL, 25 μg / mL, 50 μg / mL and 100 μg / mL of the polypeptide of the present invention respectively for 8 hours, wash thoroughly with PBS 3 times to remove the polypeptide, and prepare 6×10 4 / mL cell suspension, as effector cells; K562 human chronic myelogenous leukemia cells in the logarithmic growth phase were made into 3×10 4 / mL cell suspension, as the target cells. The effector cell suspension and the target cell suspension were inoculated into 96-well culture plates in equal volumes (immediate effect-to-target ratio 2:1), and a single effector cell well, a single target cell well and a blank well were set up at the same time, with 5 replicate wells in each group. At 37°C, 5% CO 2 Incubate in the incubator for 8 hours; add 10 μL of CCK-8 reagent, incubate for 4 hours, measure the absorbance (OD) of ...
PUM
Property | Measurement | Unit |
---|---|---|
Molecular weight | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com